Literature DB >> 21901837

Dystrophic serotonin axons in postmortem brains from young autism patients.

Efrain C Azmitia1, Jorawer S Singh, Xiao P Hou, Jerzy Wegiel.   

Abstract

Autism causes neuropathological changes in varied anatomical loci. A coherent neural mechanism to explain the spectrum of autistic symptomatology has not been proposed because most anatomical researchers focus on point-to-point functional neural systems (e.g., auditory and social networks) rather than considering global chemical neural systems. Serotonergic neurons have a global innervation pattern. Disorders Research Program, AS073234, Program Project (JW). Their cell bodies are found in the midbrain but they project their axons throughout the neural axis beginning in the fetal brain. This global system is implicated in autism by animal models and by biochemical, imaging, pharmacological, and genetics studies. However, no anatomical studies of the 5-HT innervation of autistic donors have been reported. Our review presents immunocytochemical evidence of an increase in 5-HT axons in postmortem brain tissue from autism donors aged 2.8-29 years relative to controls. This increase is observed in the principle ascending fiber bundles of the medial and lateral forebrain bundles, and in the innervation density of the amygdala and the piriform, superior temporal, and parahippocampal cortices. In autistic donors 8 years of age and up, several types of dystrophic 5-HT axons were seen in the termination fields. One class of these dystrophic axons, the thick heavily stained axons, was not seen in the brains of patients with neurodegenerative diseases. These findings provide morphological evidence for the involvement of serotonin neurons in the early etiology of autism, and suggest new therapies may be effective to blunt serotonin's trophic actions during early brain development in children.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21901837      PMCID: PMC4112519          DOI: 10.1002/ar.21243

Source DB:  PubMed          Journal:  Anat Rec (Hoboken)        ISSN: 1932-8486            Impact factor:   2.064


  107 in total

1.  The serotoninergic innervation of cerebral cortex: different classes of axon terminals arise from dorsal and median raphe nuclei.

Authors:  B E Kosofsky; M E Molliver
Journal:  Synapse       Date:  1987       Impact factor: 2.562

2.  Autism in fetal alcohol syndrome: a report of six cases.

Authors:  J L Nanson
Journal:  Alcohol Clin Exp Res       Date:  1992-06       Impact factor: 3.455

3.  Down syndrome children often have brain with maturation delay, retardation of growth, and cortical dysgenesis.

Authors:  K E Wisniewski
Journal:  Am J Med Genet Suppl       Date:  1990

4.  Autism and developmental abnormalities in children with perinatal cocaine exposure.

Authors:  E Davis; I Fennoy; D Laraque; N Kanem; G Brown; J Mitchell
Journal:  J Natl Med Assoc       Date:  1992-04       Impact factor: 1.798

5.  Serotoninergic terminal transporters are differentially affected in Parkinson's disease and progressive supranuclear palsy: an autoradiographic study with [3H]citalopram.

Authors:  G Chinaglia; B Landwehrmeyer; A Probst; J M Palacios
Journal:  Neuroscience       Date:  1993-06       Impact factor: 3.590

6.  Prenatal cocaine exposure disrupts the development of the serotonergic system.

Authors:  H M Akbari; H K Kramer; P M Whitaker-Azmitia; L P Spear; E C Azmitia
Journal:  Brain Res       Date:  1992-02-14       Impact factor: 3.252

7.  Regeneration of serotonergic immunoreactive fibers in the brain of 5,6-dihydroxytryptamine treated rat.

Authors:  S Ueda; M Kawata
Journal:  J Hirnforsch       Date:  1994

8.  Whole blood serotonin in autistic and normal subjects.

Authors:  G M Anderson; D X Freedman; D J Cohen; F R Volkmar; E L Hoder; P McPhedran; R B Minderaa; C R Hansen; J G Young
Journal:  J Child Psychol Psychiatry       Date:  1987-11       Impact factor: 8.982

9.  Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease.

Authors:  G M Halliday; Y W Li; P C Blumbergs; T H Joh; R G Cotton; P R Howe; W W Blessing; L B Geffen
Journal:  Ann Neurol       Date:  1990-04       Impact factor: 10.422

Review 10.  Neurotoxicity of MDMA and related compounds: anatomic studies.

Authors:  M E Molliver; U V Berger; L A Mamounas; D C Molliver; E O'Hearn; M A Wilson
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

View more
  14 in total

Review 1.  Autism spectrum disorder: neuropathology and animal models.

Authors:  Merina Varghese; Neha Keshav; Sarah Jacot-Descombes; Tahia Warda; Bridget Wicinski; Dara L Dickstein; Hala Harony-Nicolas; Silvia De Rubeis; Elodie Drapeau; Joseph D Buxbaum; Patrick R Hof
Journal:  Acta Neuropathol       Date:  2017-06-05       Impact factor: 17.088

2.  Persistent Angiogenesis in the Autism Brain: An Immunocytochemical Study of Postmortem Cortex, Brainstem and Cerebellum.

Authors:  E C Azmitia; Z T Saccomano; M F Alzoobaee; M Boldrini; P M Whitaker-Azmitia
Journal:  J Autism Dev Disord       Date:  2016-04

3.  Etiology of autistic features: the persisting neurotoxic effects of propionic acid.

Authors:  Afaf K El-Ansary; Abir Ben Bacha; Malak Kotb
Journal:  J Neuroinflammation       Date:  2012-04-24       Impact factor: 8.322

Review 4.  Evidence for dysregulation of axonal growth and guidance in the etiology of ASD.

Authors:  Kathryn McFadden; Nancy J Minshew
Journal:  Front Hum Neurosci       Date:  2013-10-22       Impact factor: 3.169

5.  PRICKLE1 interaction with SYNAPSIN I reveals a role in autism spectrum disorders.

Authors:  Lily Paemka; Vinit B Mahajan; Jessica M Skeie; Levi P Sowers; Salleh N Ehaideb; Pedro Gonzalez-Alegre; Toshikuni Sasaoka; Hirotaka Tao; Asuka Miyagi; Naoto Ueno; Keizo Takao; Tsuyoshi Miyakawa; Shu Wu; Benjamin W Darbro; Polly J Ferguson; Andrew A Pieper; Jeremiah K Britt; John A Wemmie; Danielle S Rudd; Thomas Wassink; Hatem El-Shanti; Heather C Mefford; Gemma L Carvill; J Robert Manak; Alexander G Bassuk
Journal:  PLoS One       Date:  2013-12-03       Impact factor: 3.240

6.  Olfactory processing in adults with autism spectrum disorders.

Authors:  Bruno Wicker; Elisabetta Monfardini; Jean-Pierre Royet
Journal:  Mol Autism       Date:  2016-01-19       Impact factor: 7.509

7.  Neonatal citalopram exposure decreases serotonergic fiber density in the olfactory bulb of male but not female adult rats.

Authors:  Junlin Zhang; Katie A Dennis; Ryan D Darling; Loai Alzghoul; Ian A Paul; Kimberly L Simpson; Rick C S Lin
Journal:  Front Cell Neurosci       Date:  2013-05-10       Impact factor: 5.505

Review 8.  The neuropathology of autism.

Authors:  Gene J Blatt
Journal:  Scientifica (Cairo)       Date:  2012-12-19

Review 9.  Neurobiological abnormalities in the first few years of life in individuals later diagnosed with autism spectrum disorder: a review of recent data.

Authors:  C S Allely; C Gillberg; P Wilson
Journal:  Behav Neurol       Date:  2014-02-09       Impact factor: 3.342

Review 10.  Evidence for Brainstem Contributions to Autism Spectrum Disorders.

Authors:  Olga I Dadalko; Brittany G Travers
Journal:  Front Integr Neurosci       Date:  2018-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.